A prospective study evaluating HCVAg kinetics in the early phase of Telaprevir/Peg-Interferon/Ribavirin treatment in patients with HCV 1 genotype infection.
Phase of Trial: Phase IV
Latest Information Update: 12 Jul 2016
At a glance
- Drugs Peginterferon (Primary) ; Ribavirin (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 12 Jul 2016 New trial record